TYBR Health’s B3 GEL System Makes its Clinical Debut in U.S.
Dr. Hanna Tammam, a fellowship-trained hand, elbow, and shoulder surgeon in Lubbock, Texas, is the first U.S. physician to use TYBR Health’s B3 GEL System in a procedure, the company announced.
B3 GEL is a collagen-based tissue protector derived from extracellular matrix (ECM). Unlike physical barriers that can be difficult to place in tight anatomical spaces, the B3 GEL System is flowable and conforms to the tissue surface and maintains biomechanical separation during the critical healing window before being naturally resorbed. Recently published research on ECM-based hydrogels suggests these materials may interact with the early healing environment, creating conditions that allow the body’s native repair process to function properly. TYBR Health is continuing to evaluate the clinical performance of the B3 GEL System through post-market surveillance and real-world clinical use.
